MSON - ミソニックス (MISONIX Inc.) ミソニックス

 MSONのチャート


 MSONの企業情報

symbol MSON
会社名 Misonix Inc. (ミソニックス)
分野(sector) Capital Goods   資本財(工業製品)
産業(industry) Medical Specialities  
業種 先端医療機器_テクノロジ―   医療関連(Health Care)
概要 事業概要 ミソニックス(MISONIX INC.)は最少量で侵入的な超音波医療機器製品の設計・製造・開発・売買を行う。同製品には脊椎手術過程に使われる「BoneScalpel」切削システム、柔かい・硬い腫瘍の乳化・除去のための「SonaStar」外科用吸引装置、生存細胞温存手術の時、失活組織及びフィブリン沈着を有効的に取除くための組織の特定辺縁切除術及び傷洗浄サービスを提供する「SonicOne」創傷清拭・創面切除用システム、並びにCovidien Ltd.との契約を通じて同社により売買される「AutoSonix」超音波切削及び凝固システム等がある。同社はまた、Johnson_Johnsonの子会社Mentor Corporationを通じて、「Lysonix」超音波アシスト脂肪吸引装置の売買を行う。平成23年10月19日、同社は実験室・法医学安全製品事業をMystaire Inc.に売却した。  ミソニックスは、米国の超音波手術装置メ―カ―。低侵襲性の超音波手術装置を設計、製造、開発、販売する。製品は背骨や顎顔面の外科手術システムBoneScalpe、腫瘍除去装置SonaStar、創傷クレンジングと切除システムSonicOneなど。また、汚染ガスを濾過する装置やその他大気汚染緩和用の環境対策製品を科学、工業用にも手掛ける。   Misonix, Inc. is a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative tissue products. Its surgical team markets and sells BoneScalpel and SonaStar, which facilitate precise bone sculpting and removal of soft and hard tumors and tissue, primarily in the areas of neurosurgery, orthopedic, plastic and maxillo-facial surgery. The Company's wound team markets and sells TheraSkin, Therion, TheraGenesis and SonicOne to debride, treat and heal chronic and traumatic wounds in inpatient, outpatient and physician office sites of service. At Misonix, Better Matters! That is why throughout the Company's history, Misonix has maintained its commitment to medical technology innovation and the development of products that radically improve outcomes for patients.
本社所在地 1938 New Highway Farmingdale NY 11735 USA
代表者氏名 Stavros G. Vizirgianakis Stavros G. Vizirgianakis
代表者役職名 President Chief Executive Officer Director 社長兼最高経営責任者(CEO)
電話番号 +1 631-694-9555
設立年月日 1955年
市場名 NASDAQ National Market System
ipoyear 1992年
従業員数 118人
url www.misonix.com
nasdaq_url https://www.nasdaq.com/symbol/mson
adr_tso
EBITDA EBITDA(百万ドル) -1.51223
終値(lastsale) 19.505
時価総額(marketcap) 184168062.975
時価総額 時価総額(百万ドル) 166.74740
売上高 売上高(百万ドル) 36.67983
企業価値(EV) 企業価値(EV)(百万ドル) 155.76794
当期純利益 当期純利益(百万ドル) -6.04773
決算概要 決算概要 BRIEF: For the fiscal year ended 30 June 2018 Misonix Inc. revenues increased 35% to $36.7M. Net loss before extraordinary items increased from $1.8M to $6M. Revenues reflect United States segment increase of 22% to $20M. Higher net loss reflects Royalty income decrease of 86% to $525K (income) Research and development expenses increase from $1.8M to $4.4M (expense).

 MSONのテクニカル分析


 MSONのニュース

   Global Surgical Tumor Ablation Market Size, Trends and Forecast 2027 By | Galil Medical, Misonix, HealthTronics  2021/08/24 13:49:37 OpenPR
The Surgical Tumor Ablation Market study provides a thorough but completes analysis of the worldwide Surgical Tumor Ablation market, including all of the major company profiles that have an impact on the market''s growth and breadth. The study is written
   Wound Cleaning Market by Trends, Dynamic Innovation in Technology and 2027 Forecasts Covid-19 Analysis | Misonix, Söring  2021/08/20 15:56:02 OpenPR
This Wound Cleaning market report provides a comprehensive overview of the major aspects that will drive market growth, such as market drivers, constraints, prospects, opportunities, restraints, current trends, and technical & industrial advancements. Industry detailed study, development and enhancement in
   Global Tumor Ablations Market 2021 Top Growing Companies Analysis and Segmentation Outlook till 2028- Angiodynamics, Medtronic, Galil Medical, Neuwave Medical, Misonix  2021/08/03 12:01:49 OpenPR
A recently updated report based namely Global Tumor Ablation Market Research Report 2021-2028 mainly elaborates the definition, types, applications, and major players of the market in detail. The report contains an overview of the market with a prime focus on
   MISONIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Misonix, Inc. - MSON  2021/07/31 14:42:00 Business Wire
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Misonix, Inc. (NasdaqGS: MSON) to Bioventus Inc. (Nasdaq: BVS). Under the terms of the proposed transaction, shareholders of Misonix may elect to receive either (i) 1.6839 shares of Bioventus class A common stock or (ii) $28.00 in cash, without interest, for each share of Misonix that they own. KSF is seeking
   SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Misonix, Inc. Buyout  2021/07/30 22:06:00 Intrado Digital Media
WILMINGTON, Del., July 30, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A. announces that it is investigating Misonix, Inc. (Misonix) (NASDAQ GM: MSON ) regarding possible breaches of fiduciary duties and other violations of law related to Misonixs agreement to be acquired by Bioventus Inc. (Bioventus) (NASDAQ GS: BVS ). Under the terms of the agreement, Misonixs shareholders will receive either 1.6839 shares of Bioventus common stock or $28.00 in cash for each share of Misonix per share.
   North America to Account for Largest Revenue Share of Orthopedic Power Tools Market | Misonix, CONMED Corporation, B Braun, Zimmer Biomet, Johnson & Johnson  2021/03/03 18:49:26 OpenPR
For the forecast period, 2017 to 2026, Fact.MR has projected a moderate expansion for the global orthopedic power tools market in its recent report. Global sales of orthopedic power tools are estimated to reach approximately US$ 2,500 Mn in revenues by 2026-end. Prominent
   Global Surgical Debridement Devices Market is to Witness Significant Growth in 2020-2026 with leading players like Soring GmbH, Zimmer Holdings, Misonix, Smith & Nephew Plc and more  2021/02/05 14:51:39 OpenPR
The Global Surgical Debridement Devices Market Report Organization's Researcher investigators specialists causes us to give our customers an exhaustive and top to bottom examination of Surgical Debridement Devices market or industry alongside its key factors, for example, market diagram and
   Misonix to Report Fiscal 2021 Second Quarter Financial Results and Host Conference Call and Webcast on February 4 - Stocks News Feed  2021/01/21 15:30:00 Stocks News Feed
FARMINGDALE, N.Y., Jan. 21, 2021 (GLOBE NEWSWIRE) — Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, announced today that it will report its fiscal 2021 second quarter financial results after the market closes on Thursday, February 4, 2021. The Company will host a conference… Read More »Misonix to Report Fiscal 2021 Second Quarter Financial Results and Host Conference Call and Webcast on February 4
   Tumor Ablation Market 2020 Analysis, Size, Share, Growth, Trends And Forecast, Leading Players are Boston Scientific, Medtronic, Misonix, Smith & Nephew, Abbott, BVM Medical  2020/10/14 15:09:54 OpenPR
The winning Tumor Ablation Market report makes available the current and forthcoming technical and financial details of the industry. Few of the chief insights of this business report include; distinct analysis of the market drivers & restraints, major market players
   Wound Debridement Market Size Estimation, Outbreak Impact Analysis, Key Insights and Application By 2027 | Coloplast, Misonix, Smith & Nephew, Medtronic, MediWound  2020/10/06 15:31:06 OpenPR
Increase in aging population, rise in prevalence of diabetes escalates incidence of chronic wounds, and growth in obesity levels drive the market. In addition, reimbursement policy and rise in demand for better healthcare fuels the market. However, possible complications after
   North America to Account for Largest Revenue Share of Orthopedic Power Tools Market | Misonix, CONMED Corporation, B Braun, Zimmer Biomet, Johnson & Johnson  2021/03/03 18:49:26 OpenPR
For the forecast period, 2017 to 2026, Fact.MR has projected a moderate expansion for the global orthopedic power tools market in its recent report. Global sales of orthopedic power tools are estimated to reach approximately US$ 2,500 Mn in revenues by 2026-end. Prominent
   Global Surgical Debridement Devices Market is to Witness Significant Growth in 2020-2026 with leading players like Soring GmbH, Zimmer Holdings, Misonix, Smith & Nephew Plc and more  2021/02/05 14:51:39 OpenPR
The Global Surgical Debridement Devices Market Report Organization's Researcher investigators specialists causes us to give our customers an exhaustive and top to bottom examination of Surgical Debridement Devices market or industry alongside its key factors, for example, market diagram and
   Misonix to Report Fiscal 2021 Second Quarter Financial Results and Host Conference Call and Webcast on February 4 - Stocks News Feed  2021/01/21 15:30:00 Stocks News Feed
FARMINGDALE, N.Y., Jan. 21, 2021 (GLOBE NEWSWIRE) — Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, announced today that it will report its fiscal 2021 second quarter financial results after the market closes on Thursday, February 4, 2021. The Company will host a conference… Read More »Misonix to Report Fiscal 2021 Second Quarter Financial Results and Host Conference Call and Webcast on February 4
   Tumor Ablation Market 2020 Analysis, Size, Share, Growth, Trends And Forecast, Leading Players are Boston Scientific, Medtronic, Misonix, Smith & Nephew, Abbott, BVM Medical  2020/10/14 15:09:54 OpenPR
The winning Tumor Ablation Market report makes available the current and forthcoming technical and financial details of the industry. Few of the chief insights of this business report include; distinct analysis of the market drivers & restraints, major market players
   Wound Debridement Market Size Estimation, Outbreak Impact Analysis, Key Insights and Application By 2027 | Coloplast, Misonix, Smith & Nephew, Medtronic, MediWound  2020/10/06 15:31:06 OpenPR
Increase in aging population, rise in prevalence of diabetes escalates incidence of chronic wounds, and growth in obesity levels drive the market. In addition, reimbursement policy and rise in demand for better healthcare fuels the market. However, possible complications after

 関連キーワード  (先端医療機器_テクノロジ― 米国株 ミソニックス MSON MISONIX Inc.)

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)